[144] The Vita Coco Company, Inc. SEC Filing

Rhea-AI Filing Summary

The Vita Coco Company, Inc. (COCO) filed a Form 144 reporting a proposed sale of 50,000 common shares. The shares are to be sold through Morgan Stanley Smith Barney LLC with an approximate sale date of 09/09/2025 and an aggregate market value of $1,919,500. The filer acquired these shares as founders' shares on 09/10/2010. There are 56,822,981 shares outstanding per the form. The filing states no securities were sold by the filer in the past three months and includes the standard representation that the selling person does not possess undisclosed material adverse information.

Positive

• Planned sale is disclosed publicly via Form 144, supporting market transparency
• Shares originated as founders' shares on 09/10/2010, with acquisition provenance provided
• Broker and approximate sale date disclosed: Morgan Stanley Smith Barney LLC; 09/09/2025
• No securities sold in the past three months by the filer, as stated on the form

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice: 50,000 founder shares planned for sale, modest relative to outstanding shares.

This Form 144 reports a planned brokered sale of 50,000 common shares valued at $1,919,500, executed through Morgan Stanley Smith Barney LLC and originating from founders' shares acquired on 09/10/2010. Relative to the reported 56,822,981 shares outstanding, the lot represents a small fraction of outstanding stock (under 0.1%). The filing also confirms no sales by the filer in the prior three months and includes the required representation regarding material non-public information. From a securities-compliance perspective, the form is a routine disclosure enabling an insider to rely on Rule 144 resale conditions.

Corporate Governance Expert

TL;DR: Disclosure aligns with regulatory expectations; provides provenance and broker details for the proposed sale.

The filing documents provenance of the shares (founders' shares acquired 09/10/2010) and identifies the executing broker and approximate sale date. It contains the standard attestation about absence of undisclosed material adverse information. For governance review, the form supplies necessary details for market transparency but does not indicate any unusual arrangements or recent related-party sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	1919500.00	56822981	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/10/2010	Founders Shares	Issuer			50000	09/10/2010	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for COCO report?

The Form 144 reports a proposed sale of 50,000 common shares of The Vita Coco Company, Inc., with an aggregate market value of $1,919,500.

When is the approximate sale date listed on the filing?

The approximate date of sale listed is 09/09/2025.

How were the shares acquired according to the filing?

The shares were acquired as founders' shares on 09/10/2010, with the issuer listed as the source.

Which broker is handling the proposed sale?

The broker named is Morgan Stanley Smith Barney LLC, address noted in the filing.

Does the filer report recent sales of issuer securities?

The filing states Nothing to Report for securities sold during the past three months.

How many shares outstanding does the filing report?

The filing reports 56,822,981 shares outstanding.